DENTALCORP HOLDINGS LTD (DNTL.CA) Stock Fundamental Analysis
Canada - Toronto Stock Exchange - TSX:DNTL - CA24874B1085 - Common Stock
11 CAD
+0.01 (+0.09%)
Overall DNTL gets a fundamental rating of 4 out of 10. We evaluated DNTL against 15 industry peers in the Health Care Providers & Services industry. DNTL has a medium profitability rating, but doesn't score so well on its financial health evaluation. DNTL has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year DNTL was profitable.
DNTL had a positive operating cash flow in the past year.
In the past 5 years DNTL always reported negative net income.
Of the past 5 years DNTL 4 years had a positive operating cash flow.
1.2 Ratios
DNTL has a Return On Assets of -0.79%. This is comparable to the rest of the industry: DNTL outperforms 53.33% of its industry peers.
DNTL has a Return On Equity (-1.54%) which is in line with its industry peers.
The Return On Invested Capital of DNTL (1.65%) is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for DNTL is significantly below the industry average of 6.98%.
The 3 year average ROIC (0.59%) for DNTL is below the current ROIC(1.65%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.79% | ||
| ROE | -1.54% | ||
| ROIC | 1.65% |
ROA(3y)-1.62%
ROA(5y)-3.33%
ROE(3y)-3.07%
ROE(5y)-9.34%
ROIC(3y)0.59%
ROIC(5y)N/A
1.3 Margins
The Operating Margin of DNTL (4.46%) is better than 73.33% of its industry peers.
DNTL's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 50.16%, DNTL is in the better half of the industry, outperforming 73.33% of the companies in the same industry.
In the last couple of years the Gross Margin of DNTL has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.46% | ||
| PM (TTM) | N/A | ||
| GM | 50.16% |
OM growth 3YN/A
OM growth 5Y18.51%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.33%
GM growth 5Y-0.08%
2. Health
2.1 Basic Checks
DNTL has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, DNTL has more shares outstanding
Compared to 5 years ago, DNTL has more shares outstanding
Compared to 1 year ago, DNTL has an improved debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 0.98, we must say that DNTL is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.98, DNTL is in line with its industry, outperforming 46.67% of the companies in the same industry.
The Debt to FCF ratio of DNTL is 8.17, which is on the high side as it means it would take DNTL, 8.17 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 8.17, DNTL perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
DNTL has a Debt/Equity ratio of 0.77. This is a neutral value indicating DNTL is somewhat dependend on debt financing.
DNTL has a Debt to Equity ratio of 0.77. This is in the better half of the industry: DNTL outperforms 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.77 | ||
| Debt/FCF | 8.17 | ||
| Altman-Z | 0.98 |
ROIC/WACC0.2
WACC8.03%
2.3 Liquidity
DNTL has a Current Ratio of 0.86. This is a bad value and indicates that DNTL is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of DNTL (0.86) is better than 66.67% of its industry peers.
A Quick Ratio of 0.72 indicates that DNTL may have some problems paying its short term obligations.
The Quick ratio of DNTL (0.72) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.86 | ||
| Quick Ratio | 0.72 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 97.41% over the past year.
The Revenue has grown by 10.09% in the past year. This is quite good.
DNTL shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.02% yearly.
EPS 1Y (TTM)97.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%366.67%
Revenue 1Y (TTM)10.09%
Revenue growth 3Y14.44%
Revenue growth 5Y15.02%
Sales Q2Q%11.91%
3.2 Future
The Earnings Per Share is expected to grow by 14.29% on average over the next years. This is quite good.
Based on estimates for the next years, DNTL will show a small growth in Revenue. The Revenue will grow by 7.46% on average per year.
EPS Next Y32.35%
EPS Next 2Y19.95%
EPS Next 3Y14.29%
EPS Next 5YN/A
Revenue Next Year10.54%
Revenue Next 2Y10.67%
Revenue Next 3Y9.73%
Revenue Next 5Y7.46%
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
DNTL is valuated rather expensively with a Price/Earnings ratio of 20.75.
Compared to the rest of the industry, the Price/Earnings ratio of DNTL indicates a somewhat cheap valuation: DNTL is cheaper than 80.00% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of DNTL to the average of the S&P500 Index (27.30), we can say DNTL is valued slightly cheaper.
DNTL is valuated rather expensively with a Price/Forward Earnings ratio of 18.65.
Based on the Price/Forward Earnings ratio, DNTL is valued a bit cheaper than the industry average as 73.33% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of DNTL to the average of the S&P500 Index (24.04), we can say DNTL is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.75 | ||
| Fwd PE | 18.65 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, DNTL is valued a bit cheaper than 73.33% of the companies in the same industry.
66.67% of the companies in the same industry are more expensive than DNTL, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.32 | ||
| EV/EBITDA | 12.95 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as DNTL's earnings are expected to grow with 14.29% in the coming years.
PEG (NY)0.64
PEG (5Y)N/A
EPS Next 2Y19.95%
EPS Next 3Y14.29%
5. Dividend
5.1 Amount
With a yearly dividend of 0.91%, DNTL is not a good candidate for dividend investing.
DNTL's Dividend Yield is a higher than the industry average which is at 1.30.
With a Dividend Yield of 0.91, DNTL pays less dividend than the S&P500 average, which is at 1.92.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.91% |
5.2 History
DNTL is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y19.95%
EPS Next 3Y14.29%
TSX:DNTL (1/13/2026, 7:00:00 PM)
11
+0.01 (+0.09%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners21.49%
Inst Owner ChangeN/A
Ins Owners0.22%
Ins Owner ChangeN/A
Market Cap2.10B
Revenue(TTM)1.66B
Net Income(TTM)-27.30M
Analysts72.31
Price Target11.45 (4.09%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.91% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)7.65%
Min EPS beat(2)-9.48%
Max EPS beat(2)24.78%
EPS beat(4)2
Avg EPS beat(4)-0.07%
Min EPS beat(4)-32.39%
Max EPS beat(4)24.78%
EPS beat(8)4
Avg EPS beat(8)-18.25%
EPS beat(12)7
Avg EPS beat(12)9.89%
EPS beat(16)8
Avg EPS beat(16)-4.74%
Revenue beat(2)0
Avg Revenue beat(2)-1.85%
Min Revenue beat(2)-2.47%
Max Revenue beat(2)-1.22%
Revenue beat(4)0
Avg Revenue beat(4)-1.56%
Min Revenue beat(4)-2.47%
Max Revenue beat(4)-0.81%
Revenue beat(8)1
Avg Revenue beat(8)-1.47%
Revenue beat(12)2
Avg Revenue beat(12)-1.37%
Revenue beat(16)3
Avg Revenue beat(16)-1.16%
PT rev (1m)0%
PT rev (3m)-6.44%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.74%
EPS NY rev (1m)0%
EPS NY rev (3m)19.02%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.02%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.12%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.75 | ||
| Fwd PE | 18.65 | ||
| P/S | 1.27 | ||
| P/FCF | 12.32 | ||
| P/OCF | 8.96 | ||
| P/B | 1.19 | ||
| P/tB | N/A | ||
| EV/EBITDA | 12.95 |
EPS(TTM)0.53
EY4.82%
EPS(NY)0.59
Fwd EY5.36%
FCF(TTM)0.89
FCFY8.11%
OCF(TTM)1.23
OCFY11.16%
SpS8.69
BVpS9.26
TBVpS-4.54
PEG (NY)0.64
PEG (5Y)N/A
Graham Number10.51
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.79% | ||
| ROE | -1.54% | ||
| ROCE | 2.29% | ||
| ROIC | 1.65% | ||
| ROICexc | 1.68% | ||
| ROICexgc | 9.86% | ||
| OM | 4.46% | ||
| PM (TTM) | N/A | ||
| GM | 50.16% | ||
| FCFM | 10.28% |
ROA(3y)-1.62%
ROA(5y)-3.33%
ROE(3y)-3.07%
ROE(5y)-9.34%
ROIC(3y)0.59%
ROIC(5y)N/A
ROICexc(3y)0.6%
ROICexc(5y)N/A
ROICexgc(3y)3.44%
ROICexgc(5y)N/A
ROCE(3y)0.82%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y24.24%
ROICexc growth 3YN/A
ROICexc growth 5Y27.79%
OM growth 3YN/A
OM growth 5Y18.51%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.33%
GM growth 5Y-0.08%
F-Score6
Asset Turnover0.48
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.77 | ||
| Debt/FCF | 8.17 | ||
| Debt/EBITDA | 5.14 | ||
| Cap/Depr | 33.53% | ||
| Cap/Sales | 3.86% | ||
| Interest Coverage | 0.86 | ||
| Cash Conversion | 88.51% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.86 | ||
| Quick Ratio | 0.72 | ||
| Altman-Z | 0.98 |
F-Score6
WACC8.03%
ROIC/WACC0.2
Cap/Depr(3y)18.24%
Cap/Depr(5y)15.74%
Cap/Sales(3y)2.58%
Cap/Sales(5y)2.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)97.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%366.67%
EPS Next Y32.35%
EPS Next 2Y19.95%
EPS Next 3Y14.29%
EPS Next 5YN/A
Revenue 1Y (TTM)10.09%
Revenue growth 3Y14.44%
Revenue growth 5Y15.02%
Sales Q2Q%11.91%
Revenue Next Year10.54%
Revenue Next 2Y10.67%
Revenue Next 3Y9.73%
Revenue Next 5Y7.46%
EBIT growth 1Y72.16%
EBIT growth 3YN/A
EBIT growth 5Y36.31%
EBIT Next Year85.67%
EBIT Next 3Y30.91%
EBIT Next 5Y18.52%
FCF growth 1Y89.57%
FCF growth 3Y58.7%
FCF growth 5Y157.47%
OCF growth 1Y92.7%
OCF growth 3Y52.18%
OCF growth 5Y50.41%
DENTALCORP HOLDINGS LTD / DNTL.CA FAQ
Can you provide the ChartMill fundamental rating for DENTALCORP HOLDINGS LTD?
ChartMill assigns a fundamental rating of 4 / 10 to DNTL.CA.
What is the valuation status for DNTL stock?
ChartMill assigns a valuation rating of 5 / 10 to DENTALCORP HOLDINGS LTD (DNTL.CA). This can be considered as Fairly Valued.
Can you provide the profitability details for DENTALCORP HOLDINGS LTD?
DENTALCORP HOLDINGS LTD (DNTL.CA) has a profitability rating of 4 / 10.
Can you provide the financial health for DNTL stock?
The financial health rating of DENTALCORP HOLDINGS LTD (DNTL.CA) is 3 / 10.